LuciBet (Bictegravir/Emtricitabine/Tenofovir Alafenamide) 50mg/200mg/25mg*30's | Generic HIV-1 | GLT

Generic Information: LuciBet (Laos)

LuciBet is a Lao-manufactured generic of the bictegravir/emtricitabine/tenofovir alafenamide combination, produced by Lucius Pharmaceuticals of Vientiane. Each tablet contains bictegravir 50 mg, emtricitabine 200 mg, and tenofovir alafenamide 25 mg, the same triple composition as the originator. As a single-tablet regimen, LuciBet delivers a complete HIV-1 treatment in one daily pill, and its Lao manufacturing base makes it an economical option for out-of-pocket buyers.

What Is LuciBet Used For?

LuciBet is used to treat HIV-1 infection in adults, either as first-line therapy for those starting treatment or as a switch for patients already virologically suppressed on another regimen. Because it contains all three drugs in a single tablet taken once daily, it removes the pill burden that undermines adherence in long-term HIV care. It is prescribed under specialist supervision after HIV-1 infection is confirmed.

How Does LuciBet (BIC/FTC/TAF) Work?

LuciBet stops HIV replication at two stages. Its bictegravir component is an integrase strand transfer inhibitor that prevents the virus from integrating its DNA into the host genome, while its emtricitabine and tenofovir alafenamide components are nucleoside reverse transcriptase inhibitors that block reverse transcription. The three drugs work together to push viral load to undetectable levels and keep the virus from developing resistance when the regimen is taken as directed.

Indications

LuciBet is indicated for HIV-1 infection in adults. As a complete regimen it should not be taken alongside other antiretrovirals, and it is intended for patients without known resistance to its three components. Regular viral-load and CD4 monitoring, together with kidney and liver checks, remains part of standard care during treatment.

Dosage

The dose is one tablet once daily, with or without food, swallowed whole. Kidney function should be assessed before and during treatment because the tenofovir alafenamide component is not recommended when creatinine clearance falls below 30 mL per minute. Hepatitis B should be tested before starting, since stopping the medicine in a coinfected patient can cause a hepatitis flare. Patients switching from another regimen should keep to their specialist's monitoring schedule.

Side Effects

Common side effects include diarrhea, nausea, and headache, usually mild and manageable. Some patients notice a small rise in serum creatinine or total bilirubin on laboratory tests, which reflects bictegravir's effect on tubular creatinine secretion rather than true kidney damage. The important safety warning is the risk of acute hepatitis B flare if the medicine is stopped in someone coinfected with HBV, along with rare cases of lactic acidosis.

Storage

Store LuciBet at room temperature, in a dry place, inside its original packaging, and away from children. No refrigeration is required, which simplifies home storage and international shipping.

Why Choose the Lao Generic LuciBet?

For uninsured or under-insured patients, a Lao generic such as LuciBet is far more economical than the branded originator, whose list price in high-income markets is several times higher. Lucius Pharmaceuticals has built a recognizable "Luci" line of affordable generics across oncology and infectious disease, and GLT sources from verified manufacturers with the documentation needed for international delivery, helping patients continue therapy without exhausting their budget.

How to Order

To order LuciBet through GLT, message us on WhatsApp at +86 15234153837 or write to [email protected]. Tell us the strength, quantity, and your country, and our team will confirm stock, sourcing origin, and delivery details. We serve hospitals, pharmacies, and individual patients alike.

FAQ

Is LuciBet a generic of Biktarvy? Yes. LuciBet is a Lao-manufactured generic containing the same three active ingredients — bictegravir, emtricitabine, and tenofovir alafenamide — at the same doses as Biktarvy.

Who makes LuciBet? LuciBet is produced by Lucius Pharmaceuticals, a Vientiane-based manufacturer known for its "Luci" line of affordable generics.

How is LuciBet taken? One tablet is taken once daily with or without food, as a complete single-tablet regimen for HIV-1.